3 Big Pharma Companies With the Best Projected Return on Investment
Some projections are easier than others.
Research firm EvaluatePharma recently published its report of where the pharmaceutical industry could be in 2022. One of the firm's projections was which big pharma companies would have the best return on investment (ROI) in the coming years.
One important thing to note about EvaluatePharma's projections, however, is that they didn't attempt to estimate an investor's ROI from buying the stocks of these companies. Instead, the firm analyzed the top pharma companies' investments in research and development (R&D) as well as mergers and acquisitions (M&A) compared to its calculations of the net present value each company's products. In other words, EvaluatePharma's effort attempted to determine each pharma company's internal ROI.
Source: Fool.com
Novo Nordisk A/S ADR Stock
With 21 Buy predictions and 1 Sell predictions Novo Nordisk A/S ADR is one of the favorites of our community.
With a target price of 146 € there is a positive potential of 30.36% for Novo Nordisk A/S ADR compared to the current price of 112.0 €.
